Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: James Baker who wrote (577)	3/8/1998 10:56:00 AM
From: BigKNY3	Respond to of 9523

Jmae Baker <<I think that the main argument of the VIVUS CEO was that heavy SAMPLING by PFE of Viagra would be a short term downer for MUSE and VIVUS. Let's remember that PFE is not making a profit on samples either. I think that Viagra with be a major product without a doubt but I consistently have said lets not over-hype the situation. Remember "buy the rumor - sell the news" is still a frequently followed formula for short term traders>> James: You make several good points in your post. Lack of demand is the primary problem for MUSE not Viagra. I doubt the VVUS CEO knows the level of future Viagra sampling. Since I am a long-term investor, I hope that PFE goes down on the "news"....so that I will be able to buy more at a discount. Have PFun! BigKNY3